1.40
price up icon1.45%   0.02
after-market Dopo l'orario di chiusura: 1.41 0.01 +0.71%
loading
Precedente Chiudi:
$1.38
Aprire:
$1.39
Volume 24 ore:
10.31M
Relative Volume:
0.85
Capitalizzazione di mercato:
$1.02B
Reddito:
$29.48M
Utile/perdita netta:
$-201.19M
Rapporto P/E:
-4.375
EPS:
-0.32
Flusso di cassa netto:
$-216.50M
1 W Prestazione:
-7.89%
1M Prestazione:
-2.10%
6M Prestazione:
-61.11%
1 anno Prestazione:
-66.43%
Intervallo 1D:
Value
$1.34
$1.455
Intervallo di 1 settimana:
Value
$1.34
$1.565
Portata 52W:
Value
$1.17
$5.06

Geron Corp Stock (GERN) Company Profile

Name
Nome
Geron Corp
Name
Telefono
(650) 473-7700
Name
Indirizzo
919 EAST HILLSDALE BOULEVARD, FOSTER CITY, CA
Name
Dipendente
229
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
GERN's Discussions on Twitter

Confronta GERN con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
GERN
Geron Corp
1.40 1.02B 29.48M -201.19M -216.50M -0.32
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
457.03 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.74 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
329.77 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
545.11 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
244.32 28.51B 3.81B -644.79M -669.77M -6.24

Geron Corp Stock (GERN) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-05-08 Downgrade Scotiabank Sector Outperform → Sector Perform
2025-02-27 Downgrade B. Riley Securities Buy → Neutral
2025-02-26 Downgrade H.C. Wainwright Buy → Neutral
2024-11-05 Iniziato H.C. Wainwright Buy
2024-10-16 Iniziato Scotiabank Sector Outperform
2024-09-09 Iniziato Leerink Partners Outperform
2024-04-30 Downgrade Robert W. Baird Outperform → Neutral
2024-04-29 Iniziato TD Cowen Buy
2024-03-15 Reiterato Needham Buy
2023-09-12 Aggiornamento Goldman Neutral → Buy
2023-03-28 Iniziato Goldman Neutral
2022-10-28 Iniziato Wedbush Outperform
2022-07-28 Ripresa B. Riley Securities Buy
2021-11-02 Iniziato Robert W. Baird Outperform
2021-02-18 Ripresa B. Riley Securities Buy
2020-08-03 Iniziato Stifel Buy
2019-11-19 Ripresa B. Riley FBR Buy
2019-09-03 Iniziato H.C. Wainwright Buy
2019-08-15 Iniziato Cantor Fitzgerald Overweight
2019-04-09 Aggiornamento Needham Hold → Buy
2019-01-31 Aggiornamento B. Riley FBR Neutral → Buy
2018-10-02 Downgrade B. Riley FBR Buy → Neutral
2018-07-05 Iniziato B. Riley FBR, Inc. Buy
2016-09-13 Reiterato FBR & Co. Outperform
2016-09-13 Reiterato FBR Capital Outperform
2015-12-07 Reiterato Piper Jaffray Overweight
2015-04-21 Iniziato Oppenheimer Outperform
2014-06-12 Aggiornamento MLV & Co Hold → Buy
2014-03-12 Downgrade MLV & Co Buy → Hold
2013-12-10 Reiterato MLV & Co Buy
2013-12-10 Aggiornamento Needham Hold → Buy
2013-11-08 Reiterato MLV & Co Buy
2013-10-16 Iniziato MLV & Co Buy
2012-08-30 Iniziato Stifel Nicolaus Buy
2012-06-28 Iniziato Needham Hold
Mostra tutto

Geron Corp Borsa (GERN) Ultime notizie

pulisher
Jun 18, 2025

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance

Jun 18, 2025
pulisher
Jun 13, 2025

With 65% institutional ownership, Geron Corporation (NASDAQ:GERN) is a favorite amongst the big guns - Yahoo Finance

Jun 13, 2025
pulisher
Jun 11, 2025

Geron: A Tough First Year For Rytelo, But Not Yet Time To Sell (Downgrade) (NASDAQ:GERN) - Seeking Alpha

Jun 11, 2025
pulisher
Jun 09, 2025

Geron Q1 2025 slides: RYTELO growth plans amid revenue challenges - Investing.com

Jun 09, 2025
pulisher
Jun 09, 2025

Geron Q1 2025 slides: RYTELO growth plans amid revenue challenges By Investing.com - Investing.com Canada

Jun 09, 2025
pulisher
Jun 06, 2025

Geron Corporation Reports First Quarter 2025 Financial Results and Recent Business Highlights - mx.advfn.com

Jun 06, 2025
pulisher
Jun 06, 2025

Class Action Filed Against Geron Corporation (GERN)May 12, 2025 Deadline to JoinContact The Gross Law Firm - mx.advfn.com

Jun 06, 2025
pulisher
Jun 03, 2025

Conservative Vision Of A Positive Future For Geron (NASDAQ:GERN) - Seeking Alpha

Jun 03, 2025
pulisher
May 30, 2025

Nuveen Asset Management LLC Purchases 14,657 Shares of Geron Co. (NASDAQ:GERN) - Defense World

May 30, 2025
pulisher
May 29, 2025

Geron showcases RYTELO benefits at oncology meetings By Investing.com - Investing.com South Africa

May 29, 2025
pulisher
May 28, 2025

Geron’s SWOT analysis: oncology firm’s stock faces growth hurdles By Investing.com - Investing.com South Africa

May 28, 2025
pulisher
May 28, 2025

Geron showcases RYTELO benefits at oncology meetings - Investing.com

May 28, 2025
pulisher
May 28, 2025

Geron Announces Presentations at ASCO and EHA Underscoring RYTELO® (imetelstat) Efficacy and Safety Across Range of LR-MDS Patients, and Showcasing Momentum of Myelofibrosis Program - Yahoo Finance

May 28, 2025
pulisher
May 28, 2025

Geron’s SWOT analysis: oncology firm’s stock faces growth hurdles - Investing.com

May 28, 2025
pulisher
May 27, 2025

Geron Corp stockholders approve equity plan amendments By Investing.com - Investing.com India

May 27, 2025
pulisher
May 27, 2025

Geron Corp stockholders approve equity plan amendments - Investing.com

May 27, 2025
pulisher
May 27, 2025

BNP Paribas Financial Markets Decreases Stock Holdings in Geron Co. (NASDAQ:GERN) - Defense World

May 27, 2025
pulisher
May 26, 2025

25,148 Shares in Geron Co. (NASDAQ:GERN) Purchased by Lazard Asset Management LLC - Defense World

May 26, 2025
pulisher
May 26, 2025

Geron Co. (NASDAQ:GERN) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World

May 26, 2025
pulisher
May 22, 2025

Bank of America Corp DE Boosts Stock Position in Geron Co. (NASDAQ:GERN) - Defense World

May 22, 2025
pulisher
May 20, 2025

Ameriprise Financial Inc. Buys 247,018 Shares of Geron Co. (NASDAQ:GERN) - Defense World

May 20, 2025
pulisher
May 19, 2025

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | GERN Stock News - GuruFocus

May 19, 2025
pulisher
May 19, 2025

Geron Grants $522K Worth of Stock Options and RSUs: New Employee Compensation Details Revealed - Stock Titan

May 19, 2025
pulisher
May 16, 2025

Stifel Financial Corp Increases Position in Geron Co. (NASDAQ:GERN) - Defense World

May 16, 2025
pulisher
May 15, 2025

Geron Corp Stock (GERN): Demand Recovery on the Rise - Value The Markets

May 15, 2025
pulisher
May 14, 2025

Northern Trust Corp Has $19.76 Million Stake in Geron Co. (NASDAQ:GERN) - Defense World

May 14, 2025
pulisher
May 13, 2025

Why Geron Corporation (GERN) Is The Best Low Priced Biotech Stock to Buy Now - Insider Monkey

May 13, 2025
pulisher
May 12, 2025

Geron Corporation Investors: Please contact the Portnoy Law - GlobeNewswire

May 12, 2025
pulisher
May 12, 2025

FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Geron - Business Wire

May 12, 2025
pulisher
May 12, 2025

GERN Investors are Reminded of an Opportunity to Lead Geron Corp - GuruFocus

May 12, 2025
pulisher
May 12, 2025

10 Best Low Priced Biotech Stocks to Buy Now - Insider Monkey

May 12, 2025
pulisher
May 12, 2025

GERN Investors are Reminded of an Opportunity to Lead Geron Corporation Securities Fraud Lawsuit with the Schall Law Firm - Benzinga

May 12, 2025
pulisher
May 11, 2025

Geron outlines strategies to boost RYTELO adoption and anticipates Phase III myelofibrosis trial results in 2026 - MSN

May 11, 2025
pulisher
May 11, 2025

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 12, 2025 in Geron LawsuitGERN - Stockhouse

May 11, 2025
pulisher
May 11, 2025

Faruqi & Faruqi Reminds Geron Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 12, 2025GERN - GlobeNewswire

May 11, 2025
pulisher
May 11, 2025

Research Analysts Set Expectations for Geron FY2028 Earnings - Defense World

May 11, 2025
pulisher
May 10, 2025

Analysts Have Lowered Expectations For Geron Corporation (NASDAQ:GERN) After Its Latest Results - simplywall.st

May 10, 2025
pulisher
May 09, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of 3D Systems Corporation - GlobeNewswire Inc.

May 09, 2025
pulisher
May 09, 2025

Geron: Rytelo's Limited Adoption And Flat Demand Signal Troubled Outlook (Rating Downgrade) - Seeking Alpha

May 09, 2025
pulisher
May 09, 2025

Lost Money on Geron Corporation (GERN)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - Stockhouse

May 09, 2025
pulisher
May 09, 2025

Geron slips as Scotiabank downgrades on sales challenges for blood cancer drug - MSN

May 09, 2025
pulisher
May 08, 2025

Geron (GERN) Faces Downgrade Amid Rytelo Rollout Concerns - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Geron stock is downgraded at Scotiabank (GERN:NASDAQ) - Seeking Alpha

May 08, 2025
pulisher
May 08, 2025

Geron (GERN) Price Target Reduced by Wedbush Amid Uptake Challen - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Geron (GERN) Experiences Notable Downgrade from Scotiabank | GER - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Geron Corporation (NASDAQ:GERN) Q1 2025 Earnings Call Transcript - Insider Monkey

May 08, 2025
pulisher
May 08, 2025

Geron (GERN) Experiences Notable Downgrade from Scotiabank | GERN Stock News - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Geron (GERN) Faces Downgrade Amid Rytelo Launch Challenges | GERN Stock News - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Class Action Filed Against Geron Corporation (GERN) Seeking Recovery for InvestorsContact Levi & Korsinsky - Stockhouse

May 08, 2025
pulisher
May 08, 2025

The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Geron Corporation(GERN) Shareholders - PR Newswire

May 08, 2025
pulisher
May 08, 2025

Geron Corp (GERN) Q1 2025 Earnings Call Highlights: Navigating Revenue Challenges and Strategic ... - Yahoo Finance

May 08, 2025

Geron Corp Azioni (GERN) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Geron Corp Azioni (GERN) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Samuels Scott Alan
EVP, Chief Legal Officer
Feb 27 '25
Buy
1.61
15,000
24,150
26,682
SCARLETT JOHN A
Chairman, President and CEO
Feb 27 '25
Buy
1.76
12,500
22,062
12,500
Ziegler James
EVP, Chief Commercial Officer
Feb 27 '25
Buy
1.60
100,000
160,000
100,000
GRETHLEIN ANDREW J
EVP, Chief Operating Officer
Jul 08 '24
Option Exercise
1.72
674,348
1,159,879
674,348
GRETHLEIN ANDREW J
EVP, Chief Operating Officer
Jul 08 '24
Sale
4.56
674,348
3,073,004
0
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
Capitalizzazione:     |  Volume (24 ore):